1. Right ventricular dysfunction in chronic heart failure: clinical laboratory and echocardiographic characteristics. (the RIVED-CHF registry).
- Author
-
Palazzuoli A, Dini FL, Agostoni P, Cartocci A, Morrone F, Tricarico L, Correale M, Mercurio V, Nodari S, Severino P, Badagliacca R, Barillà F, Paolillo S, and Filardi PP
- Subjects
- Humans, Prospective Studies, Chronic Disease, Italy epidemiology, Prognosis, Hypertension, Pulmonary physiopathology, Hypertension, Pulmonary diagnosis, Hypertension, Pulmonary diagnostic imaging, Hypertension, Pulmonary mortality, Stroke Volume physiology, Ventricular Function, Left, Echocardiography methods, Predictive Value of Tests, Heart Failure physiopathology, Heart Failure diagnosis, Heart Failure complications, Heart Failure diagnostic imaging, Ventricular Dysfunction, Right physiopathology, Ventricular Dysfunction, Right diagnostic imaging, Ventricular Dysfunction, Right etiology, Registries, Ventricular Function, Right
- Abstract
Background: Right ventricular dysfunction (RVD) and pulmonary hypertension have been recognized as two important prognostic features in patients with left side heart failure. Current literature does not distinguish between right heart failure (RHF) and RVD, and the two terms are used indiscriminately to describe pulmonary hypertension and RVD as well as clinical sign of RHF. Therefore, the right ventricle (RV) adaptation across the whole spectrum of left ventricular ejection fraction (LVEF) values has been poorly investigated., Methods: This is a multicenter observational prospective study endorsed by the Italian Society of Cardiology aiming to analyze the concordance between the signs and symptoms of RHF and echocardiographic features of RVD. The protocol will assess patients affected by chronic heart failure in stable condition regardless of the LVEF threshold by clinical, laboratory, and detailed echocardiographic study. During the follow-up period, patients will be observed by direct check-up visit and/or virtual visits every 6 months for a mean period of 3 years. All clinical laboratory and echocardiographic data will be recorded in a web platform system accessible for all centers included in the study., Results: The main study goals are: to investigate the concordance and discordance between clinical signs of RHF and RVD measured by ultrasonographic examination; to evaluate prognostic impact (in terms of cardiovascular mortality and heart failure hospitalization) of RVD and RHF during a mean follow-up period of 3 years; to investigate the prevalence of different right ventricular maladaptation (isolated right ventricular dilatation, isolated pulmonary hypertension, combined pattern) and the related prognostic impact., Conclusions: With this protocol, we would investigate the three main RVD patterns according to heart failure types and stages; we would clarify different RVD and pulmonary hypertension severity according to the heart failure types. Additionally, by a serial multiparametric analysis of RV, we would provide a better definition of RVD stage and how much is it related with clinical signs of RHF (ClinicalTrials.gov Identifier: NCT06002321)., (Copyright © 2024 Italian Federation of Cardiology - I.F.C. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF